Rigel Pharmaceuticals Inc (RIGL)
Deferred Revenue
$27.97M
Quarterly · Period ending: · USD
RIGL Deferred Revenue
Latest reported$27.97Mperiod ending
Latest reported$27.97Mperiod ending
RIGL Quarterly Deferred Revenue ($2.37M → $27.97M)
Quarterly deferred revenue
High-resolution chart · PNG
RIGL deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 27,974,000 | |
| 0 | |
| 1,355,000 | |
| 0 | |
| 30,857,000 | |
| 1,355,000 | |
| 27,795,000 | |
| 1,355,000 | |
| 1,355,000 | |
| 1,355,000 | |
| 17,039,000 | |
| 1,355,000 | |
| 1,355,000 | |
| 15,457,000 | |
| 13,514,000 | |
| 1,369,000 | |
| 1,543,000 | |
| 2,097,000 | |
| 10,511,000 | |
| 3,157,000 | |
| 5,813,000 | |
| 9,500,000 | |
| 3,018,000 | |
| 3,069,000 | |
| 3,215,000 | |
| 2,053,000 | |
| 25,288,000 | |
| 1,587,000 | |
| 1,362,000 | |
| 1,532,000 | |
| 1,030,000 | |
| 0 | |
| 0 | |
| 0 | |
| -284,000 | |
| -1,248,000 | |
| -2,196,000 | |
| -3,127,000 | |
| -3,222,000 | |
| -3,167,000 | |
| 3,760,000 | |
| 8,593,000 | |
| 13,427,000 | |
| 18,261,000 | |
| 19,335,000 | |
| 19,335,000 | |
| -2,803,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 666,000 | |
| 531,000 | |
| 397,000 | |
| 262,000 | |
| 129,000 | |
| -134,000 | |
| 105,000 | |
| -549,000 | |
| -755,000 | |
| 0 | |
| 47,283,000 | |
| 100,466,000 | |
| -1,061,000 | |
| -1,114,000 | |
| 589,000 | |
| 634,000 | |
| 3,174,000 | |
| 13,909,000 | |
| 10,419,000 | |
| 5,948,000 | |
| 10,164,000 | |
| 0 | |
| 0 | |
| 1,471,000 | |
| 3,066,000 | |
| 5,143,000 | |
| 7,221,000 | |
| 13,656,000 | |
| 15,567,000 | |
| 8,040,000 | |
| 8,260,000 | |
| 8,494,000 | |
| 3,728,000 | |
| 922,000 | |
| 1,076,000 | |
| 1,408,000 | |
| 2,242,000 | |
| 3,194,000 | |
| 3,525,000 | |
| 3,775,000 | |
| 4,061,000 | |
| 4,027,000 | |
| 3,778,000 | |
| 4,425,000 | |
| 3,264,000 | |
| 4,632,000 |